ESC 365 - Greater efficacy of prasugrel and ticagrelor administered at first medical contact compared to a switching strategy during the first hours after primary percutaneous coronary intervention

ESC Premium Access

Greater efficacy of prasugrel and ticagrelor administered at first medical contact compared to a switching strategy during the first hours after primary percutaneous coronary intervention

Session: Rapid platelet P2Y12 iinhibition in acute coronary syndromes

Topic: Thrombosis and platelets

Speaker: Doctor A. Marcano Fernandez (L'hospitalet De Llobregat, ES)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Ana Lucrecia Marcano Fernandez

L'hospitalet De Llobregat (Spain)

0 follower

4 more presentations in this session

State of the art in platelet P2Y12 iinhibition in acute coronary syndromes

Speaker: Professor J. Collet (Paris, FR)

Chewing versus traditional swallowing of ticagrelor to accelerate platelet inhibition in acute coronary syndrome- the CHEERS study

Speaker: Doctor E. Asher (Jerusalem, IL)

Cangrelor compared with clopidogrel in patients with prior myocardial infarction - Insights from the CHAMPION trials

Speaker: Doctor A. Eisen (Petah Tikva, IL)

Future direction for research in platelet P2Y12 iinhibition in acute coronary syndromes

Speaker: Professor K. Huber (Vienna, AT)

Access the full session

Rapid platelet P2Y12 iinhibition in acute coronary syndromes

Speakers: Doctor A. Marcano Fernandez, Professor J. Collet, Doctor E. Asher, Doctor A. Eisen, Professor K. Huber

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources